CinnaGen
From Wikipedia, the free encyclopedia
CinnaGen is an Iran based biotechnology company, the biggest in the region. It has more than 10 years of experience in manufacturing of molecular biology, biopharmaceuticals and diagnostic products. Founded in 1992, CinnaGen currently manufactures more than 42 products and distributes more than 120 different laboratory diagnostic reagents for in vitro use.
CinnaGen is the only biotechnology company in the region with a research and development goal and has gained expertise and extensive experience in the areas of molecular biology, recombinant DNA technology and cell biology as the backbone of their products. In addition, CinnaGen has acted as the research consultant in biotechnology for other manufacturers in the region for development of new products.
In collaboration with the Fraunhofer Institute in Germany Cinnagen developed Cinnovex, which in 2007 became the first biogeneric clone of interferon-beta to be used for treatment of multiple sclerosis when it was approved by the Iranian Food and Drug Administration.[1][2]
[edit] References
- ^ "Aus Deutschland für Kranke in Iran (From Germany for the sick in Iran)", Wiener Zeitung, 2007-03-20. Retrieved on 2008-03-31. (German)
- ^ "First biogeneric therapeutic protein from Fraunhofer Institute introduced to the market", BioRegio STERN, 2007-01-22. Retrieved on 2008-03-31.
